Lung Cancer Clinical Trial

Health Education Approach to Lung Screening

Summary

Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)

View Full Description

Full Description

This is a single-arm study of a patient navigation intervention to increase access to lung cancer screening (LCS).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Meets current USPSTF guidelines for lunc cancer screening (LCS)
20 pack-year smoking history Note: A pack-year is a way of calculating how much a person has smoked in their lifetime.

One pack-year is the equivalent of smoking an average of 20 cigarettes-1 pack-per day for a year.

Currently smokes or has quit smoking within the past 15 years
Identifies as Black or African-American Note: Both Hispanic/Latino and Non-Hispanic/Latino patients are eligible as long as they also identify as Black or African-American (eg, Afro-Latino).
Willing to complete all navigation-related study activities
Able to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

A patient who meets any of the following exclusion criteria is ineligible to participate in the study:

Known history of cancer (except squamous cell skin cancer), chronic obstructive pulmonary disease (COPD), emphysema, or coughing up blood in the past 5 years, as reported by the individual
Inability to speak English
Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements

Study is for people with:

Lung Cancer

Estimated Enrollment:

225

Study ID:

NCT06070870

Recruitment Status:

Recruiting

Sponsor:

Virginia Commonwealth University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

University of North Carolina-Chapel Hill
Carrboro North Carolina, 27510, United States More Info
Christopher Lyu, MPA
Contact
919-966-2865
[email protected]
Alison Brenner, MD
Contact
(919) 966-2865
Alison Brenner, MD
Principal Investigator
Medical University of South Carolina
Charleston South Carolina, 29425, United States More Info
Ellen Gomez, MA
Contact
843-876-2428
[email protected]
Marvella Ford, MD
Contact
843-876-2428
Marvella Ford, MD
Principal Investigator
Virginia Commonwealth University
Richmond Virginia, 23298, United States More Info
Massey CPC Team
Contact
804-828-1965
[email protected]
CTO Clinical Operations Managers
Contact
[email protected]
Vanessa Sheppard, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

225

Study ID:

NCT06070870

Recruitment Status:

Recruiting

Sponsor:


Virginia Commonwealth University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.